ProCE Banner Activity

Overcoming Treatment Challenges With New Targeted Agents and Formulations

Slideset Download
Jeffrey E. Lancet, MD, provides expert insights and guidance on the best strategies to treat elderly and other patients with newly diagnosed AML.

Released: December 06, 2019

Expiration: December 04, 2020

Share

Faculty

Jeffrey E. Lancet

Jeffrey E. Lancet, MD

Senior Member & Professor
Chair,
 Department of Malignant Hematology
Moffitt Cancer Center
Tampa, Florida

Provided by

Provided by National Comprehensive Cancer Network.
ProCE Banner

Supporters

Supported by educational grants from

Actinium

Boston Biomedical

Jazz Pharmaceuticals, Inc.

Pfizer, Inc.

Partners

NCCN

ProCE Banner

Faculty Disclosure

Primary Author

Jeffrey E. Lancet, MD

Senior Member & Professor
Chair,
 Department of Malignant Hematology
Moffitt Cancer Center
Tampa, Florida